 Connection
Melanie Gleason to Anti-Asthmatic Agents
This is a "connection" page, showing publications Melanie Gleason has written about Anti-Asthmatic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.338 |
|
|
|
-
Anderson WC, Gleason MC, Miyazawa N, Szefler SJ. Approaching Current and New Drug Therapies for Pediatric Asthma. Pediatr Clin North Am. 2017 12; 64(6):1197-1207.
Score: 0.113
-
Kruzick T, Covar RA, Gleason M, Cicutto L, White M, Shocks D, Szefler SJ. Does access to care equal asthma control in school-age children? J Allergy Clin Immunol. 2009 Aug; 124(2):381-3.
Score: 0.063
-
Neville KA, Szefler SJ, Abdel-Rahman SM, Lahu G, Zech K, Herzog R, Bethke TD, Gleason MC, Kearns GL. Single-dose pharmacokinetics of roflumilast in children and adolescents. J Clin Pharmacol. 2008 Aug; 48(8):978-85.
Score: 0.058
-
Spahn JD, Covar RA, Jain N, Gleason M, Shimamoto R, Szefler SJ, Gelfand EW. Effect of montelukast on peripheral airflow obstruction in children with asthma. Ann Allergy Asthma Immunol. 2006 Apr; 96(4):541-9.
Score: 0.050
-
Szefler SJ, Whelan G, Gleason M, Spahn JD. The need for pediatric studies of allergy and asthma medications. Curr Allergy Asthma Rep. 2003 Nov; 3(6):478-83.
Score: 0.043
-
Bender BG, Ellison MC, Gleason M, Murphy JR, Sundstrom DA, Szefler SJ. Minimizing attrition in a long-term clinical trial of pediatric asthma. Ann Allergy Asthma Immunol. 2003 Aug; 91(2):168-76.
Score: 0.010
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|